These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9825826)

  • 1. Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy.
    Toth CM; Pascual M; Chung RT; Graeme-Cook F; Dienstag JL; Bhan AK; Cosimi AB
    Transplantation; 1998 Nov; 66(9):1254-8. PubMed ID: 9825826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
    Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
    Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.
    Cimsit B; Assis D; Caldwell C; Arvelakis A; Taddei T; Kulkarni S; Schilsky M; Emre S
    Transplant Proc; 2011 Apr; 43(3):905-8. PubMed ID: 21486625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus-related fibrosing cholestatic hepatitis in a renal transplant recipient.
    Hooda AK; Puri P; Narula AS; Raychaudhury N; Varghese SJ; Basu A
    Indian J Gastroenterol; 2006; 25(6):308-9. PubMed ID: 17264433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrosing cholestatic hepatitis after successful interferon and ribavirin therapy for recurrent hepatitis C post living related liver transplantation: a case report.
    Yamamoto T; Tanaka S; Uenishi T; Kanazawa A; Kubo S; Hirohashi K
    Osaka City Med J; 2014 Dec; 60(2):95-100. PubMed ID: 25803885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment with telaprevir of post-transplant fibrosing cholestatic hepatitis C in an HIV co-infected patient.
    Marciano S; Galdame OA; Barcan LA; Gadano AC
    Acta Gastroenterol Latinoam; 2015 Mar; 45(1):76-9. PubMed ID: 26076519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrosing cholestatic hepatitis in a kidney transplant recipient with hepatitis C virus.
    Shinzato T; Kubo T; Shimizu T; Nanmoku K; Yagisawa T
    CEN Case Rep; 2019 May; 8(2):101-105. PubMed ID: 30604247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating fibrosing cholestatic hepatitis C with sofosbuvir and ribavirin: a matched analysis.
    Saab S; Jimenez M; Bau S; Goo T; Zhao D; Durazo F; Han S; El Kabany M; Kaldas F; Tong MJ; Busuttil RW
    Clin Transplant; 2015 Sep; 29(9):813-9. PubMed ID: 26147216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fulminant hepatic failure in a renal transplant recipient with positive hepatitis B surface antigens: a case report of fibrosing cholestatic hepatitis.
    Hung YB; Liang JT; Chu JS; Chen KM; Lee CS
    Hepatogastroenterology; 1995; 42(6):913-8. PubMed ID: 8847045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.
    Charlton M; Everson GT; Flamm SL; Kumar P; Landis C; Brown RS; Fried MW; Terrault NA; O'Leary JG; Vargas HE; Kuo A; Schiff E; Sulkowski MS; Gilroy R; Watt KD; Brown K; Kwo P; Pungpapong S; Korenblat KM; Muir AJ; Teperman L; Fontana RJ; Denning J; Arterburn S; Dvory-Sobol H; Brandt-Sarif T; Pang PS; McHutchison JG; Reddy KR; Afdhal N;
    Gastroenterology; 2015 Sep; 149(3):649-59. PubMed ID: 25985734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis.
    Vukotic R; Conti F; Fagiuoli S; Morelli MC; Pasulo L; Colpani M; Foschi FG; Berardi S; Pianta P; Mangano M; Donato MF; Malinverno F; Monico S; Tamè M; Mazzella G; Belli LS; Viganò R; Carrai P; Burra P; Russo FP; Lenci I; Toniutto P; Merli M; Loiacono L; Iemmolo R; Degli Antoni AM; Romano A; Picciotto A; Rendina M; Andreone P;
    J Viral Hepat; 2017 Oct; 24(10):858-864. PubMed ID: 28370880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of fibrosing cholestatic hepatitis with pegylated interferon, ribavirin and sofosbuvir after a combined kidney-liver transplantation.
    Delabaudière C; Lavayssière L; Dörr G; Muscari F; Danjoux M; Sallusto F; Peron JM; Bureau C; Rostaing L; Izopet J; Kamar N
    Transpl Int; 2015 Feb; 28(2):255-8. PubMed ID: 25159822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver Transplantation.
    Leroy V; Dumortier J; Coilly A; Sebagh M; Fougerou-Leurent C; Radenne S; Botta D; Durand F; Silvain C; Lebray P; Houssel-Debry P; Kamar N; D'Alteroche L; Petrov-Sanchez V; Diallo A; Pageaux GP; Duclos-Vallee JC;
    Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1993-2001.e1-2. PubMed ID: 26044317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment with pegylated interferon and ribavirin in a patient with fibrosing cholestatic hepatitis due to recurrent hepatitis C after liver transplantation].
    Kim BK; Kwon SY; Ko SY; Choe WH; Lee CH; Han HS; Chang SH
    Korean J Hepatol; 2008 Dec; 14(4):519-24. PubMed ID: 19119247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous interferon during the anhepatic phase of liver retransplantation and prevention of recurrence of cholestatic hepatitis C virus.
    Kwo PY; Saxena R; Cummings OW; Tector AJ
    Liver Transpl; 2007 Dec; 13(12):1710-3. PubMed ID: 18044743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapidly progressive fibrosing cholestatic hepatitis--hepatitis C virus in HIV coinfection.
    Rosenberg PM; Farrell JJ; Abraczinskas DR; Graeme-Cook FM; Dienstag JL; Chung RT
    Am J Gastroenterol; 2002 Feb; 97(2):478-83. PubMed ID: 11866292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrosing Cholestatic Hepatitis in a Complicated Case of an Adult Recipient After Liver Transplantation: Diagnostic Findings and Therapeutic Dilemma.
    Hori T; Onishi Y; Kamei H; Kurata N; Ishigami M; Ishizu Y; Ogura Y
    Am J Case Rep; 2016 Aug; 17():597-604. PubMed ID: 27545580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience of fibrosing cholestatic hepatitis with hepatitis C virus in kidney transplant recipients.
    Siddiqui AR; Abbas Z; Luck NH; Hassan SM; Aziz T; Mubarak M; Naqvi SA; Rizvi SA
    Transplant Proc; 2012 Apr; 44(3):721-4. PubMed ID: 22483477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fibrosing cholestatic hepatitis--disease not only of transplanted patients. A report of eight cases].
    Honsová E; Sperl J
    Cesk Patol; 2011 Apr; 47(2):55-8. PubMed ID: 21604436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased hepatic progenitor cell response and ductular reaction in patients with severe recurrent HCV post-liver transplantation.
    Sclair SN; Fiel MI; Wu HS; Doucette J; Aloman C; Schiano TD
    Clin Transplant; 2016 Jun; 30(6):722-30. PubMed ID: 27027987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.